Advanced Solid Tumors With FGFR3 Mutation
1 clinical trials · Condition
◉ Watch Advanced Solid Tumors With FGFR3 Mutation
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies (NCT01004224) | Novartis Pharmaceuticals | 2009-12-11 |
Track Advanced Solid Tumors With FGFR3 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.